176 related articles for article (PubMed ID: 10555901)
1. Thrombophilic factors and their relation to thromboembolic and other clinical manifestations in Behçet's disease.
Mader R; Ziv M; Adawi M; Mader R; Lavi I
J Rheumatol; 1999 Nov; 26(11):2404-8. PubMed ID: 10555901
[TBL] [Abstract][Full Text] [Related]
2. Thrombophilic risk factors and homocysteine levels in Behçet's disease in eastern Spain and their association with thrombotic events.
Ricart JM; Vayá A; Todolí J; Calvo J; Villa P; Estellés A; España F; Santaolaria M; Corella D; Aznar J
Thromb Haemost; 2006 Apr; 95(4):618-24. PubMed ID: 16601831
[TBL] [Abstract][Full Text] [Related]
3. Anticardiolipin antibodies and retinal vascular complications in Behçet's disease.
Ozdemir Y; Onder F; Yarangümeli A; Küçükkuyumcu C; Kural G
Ophthalmic Surg Lasers; 1997 Aug; 28(8):653-6. PubMed ID: 9268996
[TBL] [Abstract][Full Text] [Related]
4. Endothelial cell activation and hypercoagulability in ocular Behçet's disease.
Probst K; Fijnheer R; Rothova A
Am J Ophthalmol; 2004 May; 137(5):850-7. PubMed ID: 15126149
[TBL] [Abstract][Full Text] [Related]
5. Resistance to activated protein C and low levels of free protein S in Greek patients with inflammatory bowel disease.
Koutroubakis IE; Sfiridaki A; Mouzas IA; Maladaki A; Kapsoritakis A; Roussomoustakaki M; Kouroumalis EA; Manousos ON
Am J Gastroenterol; 2000 Jan; 95(1):190-4. PubMed ID: 10638581
[TBL] [Abstract][Full Text] [Related]
6. Thrombosis in systemic lupus erythematosus: congenital and acquired risk factors.
Afeltra A; Vadacca M; Conti L; Galluzzo S; Mitterhofer AP; Ferri GM; Del Porto F; Caccavo D; Gandolfo GM; Amoroso A
Arthritis Rheum; 2005 Jun; 53(3):452-9. PubMed ID: 15934123
[TBL] [Abstract][Full Text] [Related]
7. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
8. Activated protein C levels in Behçet's disease and risk of venous thrombosis.
Navarro S; Ricart JM; Medina P; Vayá A; Villa P; Todolí J; Estellés A; Micó ML; Aznar J; España F
Br J Haematol; 2004 Aug; 126(4):550-6. PubMed ID: 15287949
[TBL] [Abstract][Full Text] [Related]
9. Factor V Leiden mutation in patients with Behçet's disease.
Oner AF; Gürgey A; Gürler A; Mesci L
J Rheumatol; 1998 Mar; 25(3):496-8. PubMed ID: 9517770
[TBL] [Abstract][Full Text] [Related]
10. [Vena cava thrombosis in Behçet's disease. Analysis of a series of 10 cases].
Houman H; Lamloum M; Ben Ghorbel I; Khiari-Ben Salah I; Miled M
Ann Med Interne (Paris); 1999 Dec; 150(8):587-90. PubMed ID: 10686638
[TBL] [Abstract][Full Text] [Related]
11. The search for a common thrombophilic state during the active state of inflammatory bowel disease.
Yurekli BP; Aksoy DY; Aybar M; Egesel T; Gurgey A; Hascelik G; Kirazli S; Haznedaroglu IC; Arslan S
J Clin Gastroenterol; 2006 Oct; 40(9):809-13. PubMed ID: 17016137
[TBL] [Abstract][Full Text] [Related]
12. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis?
Linnemann B; Schindewolf M; Zgouras D; Erbe M; Jarosch-Preusche M; Lindhoff-Last E
Thromb Res; 2008; 121(6):743-50. PubMed ID: 17804043
[TBL] [Abstract][Full Text] [Related]
13. Thrombotic events in systemic lupus erythematosus. Its association with acquired and inherited thrombophilic defects.
Vayá A; Santaolaria M; Micó L; Calvo J; Oropesa R; Villa P; Todoli J; Simó M; Corella D; Ricart JM
Clin Hemorheol Microcirc; 2008; 40(2):79-87. PubMed ID: 19029633
[TBL] [Abstract][Full Text] [Related]
14. Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis.
Silingardi M; Salvarani C; Boiardi L; Accardo P; Iorio A; Olivieri I; Cantini F; Salvi F; La Corte R; Triolo G; Ciccia F; Ghirarduzzi A; Filippini D; Paolazzi G; Iori I
Arthritis Rheum; 2004 Apr; 51(2):177-83. PubMed ID: 15077257
[TBL] [Abstract][Full Text] [Related]
15. Basic parameters of thrombophilia in ocular Behçet disease with posterior segment involvement.
Citirik M; Haznedaroglu IC; Teberik K; Soykan E; Zilelioglu O
Br J Ophthalmol; 2009 Oct; 93(10):1382-6. PubMed ID: 19635722
[TBL] [Abstract][Full Text] [Related]
16. Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement.
Durmazlar SP; Ulkar GB; Eskioglu F; Tatlican S; Mert A; Akgul A
Int J Dermatol; 2009 Mar; 48(3):259-64. PubMed ID: 19261013
[TBL] [Abstract][Full Text] [Related]
17. Thrombosis risk in systemic lupus erythematosus: the role of thrombophilic risk factors.
Sallai KK; Nagy E; Bodó I; Mohl A; Gergely P
Scand J Rheumatol; 2007; 36(3):198-205. PubMed ID: 17657674
[TBL] [Abstract][Full Text] [Related]
18. Association of periprocedural neurological deficit in carotid stenting with increased anticardiolipin antibodies.
Steiner S; Sadushi R; Bartok A; Hammer A; Quehenberger P; Mannhalter C; Koppensteiner R; Minar E; Kopp CW
Thromb Res; 2009 Apr; 123(6):827-31. PubMed ID: 18817951
[TBL] [Abstract][Full Text] [Related]
19. Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothombin gene G20210A mutations on deep venous thrombogenesis in Behçet's disease.
Toydemir PB; Elhan AH; Tükün A; Toydemir R; Gürler A; Tüzüner A; Bökesoy I
J Rheumatol; 2000 Dec; 27(12):2849-54. PubMed ID: 11128675
[TBL] [Abstract][Full Text] [Related]
20. Association of factor V Leiden with Behçet's disease.
Mammo L; Al-Dalaan A; Bahabri SS; Saour JN
J Rheumatol; 1997 Nov; 24(11):2196-8. PubMed ID: 9375883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
